Modulation properties of factors released by bone marrow stromal cells on activated microglia: An in vitro study

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Cizkova, Dasa ^a,b   Devaux, Stéphanie ^a   Le Marrec Croq, Françoise ^a   Franck, Julien ^a   Slovinska, Lucia ^b   Blasko, Juraj ^b   Rosocha, Jan ^c   Spakova, Timea ^c   Lefebvre, Christophe ^a   Fournier, Isabelle ^a   Salzet, Michel ^a  

^a INSERM   (France)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE MEDIUM; IMMUNOLOGIC FACTOR; SIGNAL PEPTIDE;

ANIMAL; BONE MARROW CELL; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; MALE; METABOLISM; MICROGLIA; PHARMACOLOGY; RAT; SECRETION (PROCESS); STROMA CELL; WISTAR RAT;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; IMMUNOLOGIC FACTORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICROGLIA; RATS; RATS, WISTAR; STROMAL CELLS;

EID: 84941135068     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07514     Document Type: Article

References (74)

1. Luria, E. A., Panasyuk, A. F. & Friedenstein, A. Y. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 11, 345-349 (1971).
2. Uccelli, A., Moretta, L. & Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8, 726-736 (2008).
3. da Silva Meirelles, L., Chagastelles, P. C. & Nardi, N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119, 2204-2213 (2006).
4. Kern, S., Eichler, H., Stoeve, J., Kluter, H. & Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301 (2006).
5. Zuk, P. A. et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279-4295 (2002).
6. Lei, J., Cheng, J., Li, Y., Li, S. & Zhang, L. CD80, but not CD86, express on cultured murine keratinocyte stem cells. Transplant Proc 37, 289-291 (2005).
7. Gotherstrom, C. et al. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematol. 90, 1017-1026 (2005).
8. Tani, H., Morris, R. J. & Kaur, P. Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci U S A 97, 10960-10965 (2000).
9. Karaoz, E. et al. Pancreatic islet derived stem cells can express co-stimulatory molecules of antigen-presenting cells. Transplant Proc 42, 3663-3670 (2010).
10. Corcione, A. et al. Human mesenchymal stem cells modulate B-cell functions. Blood 107, 367-372 (2006).
11. Krampera, M. et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101, 3722-3729 (2003).
12. Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C. & Moretta, L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107, 1484-1490 (2006).
13. Jiang, X. X. et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105, 4120-4126 (2005).
14. Raffaghello, L. et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 26, 151-162 (2008).
15. Chen, J. et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73, 778-786 (2003).
16. Park, H. J., Lee, P. H., Bang, O. Y., Lee, G. & Ahn, Y. H. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem 107, 141-151 (2008).
17. Wu, D. C. et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22, 1763-1771 (2002).
18. van Velthoven, C. T., Kavelaars, A., van Bel, F. & Heijnen, C. J. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 24, 387-393 (2010).
19. Tator, C. H. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 5, 407-413 (1995).
20. Schwab, M. E. & Bartholdi, D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiological rev 76, 319-370 (1996).
21. Schwartz, M., Moalem, G., Leibowitz-Amit, R. & Cohen, I. R. Innate and adaptive immune responses can be beneficial for CNS repair. Trends in Neurosc. 22, 295-299 (1999).
22. Schwab, J. M., Zhang, Y., Kopp, M. A., Brommer, B. & Popovich, P. G. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp Neurol 258C, 121-129 (2014).
23. Rolls, A., Shechter, R. & Schwartz, M. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10, 235-241 (2009).
24. Lalancette-Hebert, M., Gowing, G., Simard, A., Weng, Y. C. & Kriz, J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27, 2596-2605 (2007).
25. Ransohoff, R. M., Liu, L. & Cardona, A. E. Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int Rev Neurobiol 82, 187-204 (2007).
26. Aloisi, F. Immune function of microglia. Glia 36, 165-179 (2001).
27. Block, M. L. & Hong, J. S. Microglia and inflammation-mediated neurodegeneration:multiple triggers with a commonmechanism. Prog Neurobiol 76, 77-98 (2005).
28. Ransohoff, R. M. & Cardona, A. E. Themyeloid cells of the central nervous system parenchyma. Nature 468, 253-262 (2010).
29. Zhou, C. et al. Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Brain Res 1269, 23-30 (2009).
30. Lee, H. J. et al. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol Aging 33, 588-602 (2012).
31. Kim, Y. J. et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 57, 13-23 (2009).
32. Yan, K. et al. Bone marrow-derived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation. PLoS One 8, e84116 (2013).
33. Cizkova, D. et al. Alterations of protein composition along the rostro-caudal axis after spinal cord injury: proteomic, in vitro and in vivo analyses. Front Cell Neurosci 8, 105 (2014).
34. Filip, S. et al. Splenectomy influences homing of transplanted stem cells in bone marrow-ablated mice. Stem Cells Dev 21, 702-709 (2012).
35. Cizkova, D. et al. Induction of mesenchymal stem cells leads to HSP72 synthesis and higher resistance to oxidative stress. Neurochem Res 31, 1011-1020 (2006).
36. Cizkova, D., Rosocha, J., Vanicky, I., Jergova, S. & Cizek, M. Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol 26, 1167-1180 (2006).
37. Ritfeld, G. J. et al. Bone marrow stromal cell-mediated tissue sparing enhances functional repair after spinal cord contusion in adult rats. Cell Transplant 21, 1561-1575 (2012).
38. Nandoe Tewarie, R. D., Hurtado, A., Bartels, R. H., Grotenhuis, J. A. & Oudega, M. A clinical perspective of spinal cord injury. Neuro Rehabilitation 27, 129-139 (2010).
39. Nandoe Tewarie, R. S., Hurtado, A., Bartels, R. H., Grotenhuis, A. & Oudega, M. Stem cell-based therapies for spinal cord injury. J Spinal Cord Med 32, 105-114 (2009).
40. Nandoe Tewarie, R. D., Hurtado, A., Levi, A. D., Grotenhuis, J. A. & Oudega, M. Bone marrow stromal cells for repair of the spinal cord: towards clinical application. Cell Transplant 15, 563-577 (2006).
41. Cizkova, D. et al. Role of transplanted bone marrow cells in response to skeletal muscle injury. Folia Biol (Praha) 57, 232-241 (2011).
42. Cizkova, D. et al. Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. J Neurotrauma 28, 1951-1961 (2011).
43. Vanicky, I., Urdzikova, L., Saganova, K., Cizkova, D. & Galik, J. A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat. J Neurotrauma 18, 1399-1407 (2001).
44. Giulian, D. & Baker, T. J. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6, 2163-2178 (1986).
45. Bocchini, V. et al. An immortalized cell line expresses properties of activated microglial cells. Journal of Neurosc. Res. 31, 616-621 (1992).
46. Smith, S. M. et al. An enhanced miniaturized assay for antimicrobial prospecting. J Microbiol Methods 72, 103-106 (2008).
47. Choi, H., Fermin, D. & Nesvizhskii, A. I. Significance analysis of spectral count data in label-free shotgun proteomics. Mol Cell Proteomics 7, 2373-2385 (2008).
48. Nesvizhskii, A., Keller, A., Kolker, E. & Abersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75 (2003).
49. Keller, A., Nesvizhskii, A. I., Kolker, E. & Aebersold, R. An explanation of the Peptide Prophet algorithm developed. Anal Chem 74, 5383-5392 (2002).
50. Ritfeld, G. J., Roos, R. A. & Oudega, M. Stem cells for central nervous system repair and rehabilitation. PMR 3, S117-122 (2011).
51. Beck, K. D. et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 133, 433-447 (2010).
52. Popovich, P. G. & Jones, T. B. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci 24, 13-17 (2003).
53. Fleming, J. C. et al. The cellular inflammatory response in human spinal cords after injury. Brain 129, 3249-3269 (2006).
54. Keane, R. W., Davis, A. R. & Dietrich, W. D. Inflammatory and apoptotic signaling after spinal cord injury. J Neurotrauma 23, 335-344 (2006).
55. Nakajima, H. et al. Transplantation of mesenchymal stem cells promotes an alternative pathway ofmacrophage activation and functional recovery after spinal cord injury. J Neurotrauma 29, 1614-1625 (2012).
56. Geffner, L. F. et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 17, 1277-1293 (2008).
57. Yoon, S. H. et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 25, 2066-2073 (2007).
58. Park, H. C. et al. Treatment of complete spinal cord injury patients by autologous bonemarrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 11, 913-922 (2005).
59. Sykova, E. et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 15, 675-687 (2006).
60. Lu, P., Jones, L. L. & Tuszynski, M. H. Axon regeneration through scars and into sites of chronic spinal cord injury. Exp Neurol 203, 8-21 (2007).
61. Carney, B. J. & Shah, K. Migration and fate of therapeutic stem cells in different brain disease models. Neurosci 197, 37-47 (2011).
62. Tambuyzer, B. R., Ponsaerts, P. & Nouwen, E. J. Microglia: gatekeepers of central nervous system immunology. J. of leukocyte biol 85, 352-370 (2009).
63. Watzlawik, J. O., Warrington, A. E. & Rodriguez, M. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation. PLoS One 8, e55149 (2013).
64. Robinson, A. P., Foraker, J. E., Ylostalo, J. & Prockop, D. J. Human stem/progenitor cells from bonemarrow enhance glial differentiation of rat neural stem cells: a role for transforming growth factor beta and Notch signaling. Stem Cells Dev 20, 289-300 (2011).
65. Au, E. et al. SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair. J Neurosci 27, 7208-7221 (2007).
66. Rivera, L. B., Bradshaw, A. D. & Brekken, R. A. The regulatory function of SPARC in vascular biology. Cell Mol Life Sci 68, 3165-3173 (2011).
67. Kular, L., Pakradouni, J., Kitabgi, P., Laurent, M. & Martinerie, C. The CCN family: a new class of inflammation modulators? Biochimie 93, 377-388 (2011).
68. Kondo, Y., Nakanishi, T., Takigawa, M. & Ogawa, N. Immunohistochemical localization of connective tissue growth factor in the rat central nervous system. Brain Res 834, 146-151 (1999).
69. Wahab, N. A., Weston, B. S. & Mason, R. M. Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 16, 340-351 (2005).
70. Schaffler, A. & Buechler, C. CTRP family: linking immunity to metabolism. Trends Endocrinol Metab 23, 194-204 (2012).
71. Siegenthaler, J. A. & Miller, M. W. Transforming growth factor beta 1 promotes cell cycle exit through the cyclin-dependent kinase inhibitor p21 in the developing cerebral cortex. J Neurosci 25, 8627-8636 (2005).
72. Kozlowski, C. & Weimer, R. M. An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo. PLoS One 7, e31814 (2012).
73. Karperien, A., Ahamme, H. & Jelinek, H. F. Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci 7, 3 (2013).
74. Rahmat, Z., Jose, S., Ramasamy, R. & Vidyadaran, S. Reciprocal interactions of mouse bone marrow-derived mesenchymal stem cells and BV2 microglia after lipopolysaccharide stimulation. Stem Cell Res Ther 4, 12 (2013).